Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Primate cell – per se
Reexamination Certificate
2008-07-15
2008-07-15
Belyavskyi, Michail A (Department: 1644)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Primate cell, per se
C435S373000, C435S378000, C435S383000
Reexamination Certificate
active
07399632
ABSTRACT:
A method of enriching mesenchymal precursor sells including the step of enriching for cells based on at least two markers. The markers may be either i) the presence of markers specific for mesenchymal precursor cells, ii) the absence of markers specific for differentiated mesenchymal cells, or iii) expression levels of markers specific for mesenchymal precursor cells. The method may include a first solid phase sorting step utilizing MACS recognizing expression of the antigen to the STRO-1 Mab, followed by a second sorting step utilizing two color FACS to screen for the presence of high level STRO-1 antigen expression as well as the expression of VCAM-1.
REFERENCES:
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5591625 (1997-01-01), Gerson et al.
patent: 5811094 (1998-09-01), Caplan
patent: 5827740 (1998-10-01), Pittenger
patent: 5922597 (1999-07-01), Verfaillie et al.
patent: 5980887 (1999-11-01), Isner et al.
patent: 6022540 (2000-02-01), Bruder et al.
patent: 6087113 (2000-07-01), Caplan et al.
patent: 6261549 (2001-07-01), Fernandez et al.
patent: 6322784 (2001-11-01), Pittenger et al.
patent: 6335195 (2002-01-01), Rodgers et al.
patent: 6387367 (2002-05-01), Davis-Sproul et al.
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 6645727 (2003-11-01), Thomas et al.
patent: 6709864 (2004-03-01), Pittenger et al.
patent: 7122178 (2006-10-01), Simmons et al.
patent: 2002/0085996 (2002-07-01), McIntosh et al.
patent: 2004/0107453 (2004-06-01), Furcht et al.
patent: 2005/0019911 (2005-01-01), Simmons et al.
patent: 2005/0158289 (2005-07-01), Simmons et al.
patent: 2005/0281790 (2005-12-01), Simmons et al.
patent: 2006/0193840 (2006-08-01), Gronthos et al.
patent: 2006/0286077 (2006-12-01), Gronthos et al.
patent: 2007/0065938 (2007-03-01), Gronthos et al.
patent: WO 99/03973 (1999-01-01), None
patent: WO 00/06701 (2000-02-01), None
patent: WO 01/04268 (2001-01-01), None
patent: WO 0111011 (2001-02-01), None
patent: WO 02/07679 (2002-01-01), None
patent: WO 2004/084921 (2004-10-01), None
patent: WO 2004/085630 (2004-10-01), None
Alberico et al (1987) Blood;69:1120.
Allen, T.D.: Haemopoietic microenvironment in vitro: Ultrastructural aspects. In Porter R. Whelan J (eds); “Microenvironments in haemopoietic and lymphoid differentiation.” CIBA Foundation Symposium 84. London: Pitman Medical, 1981, pp. 38-67.
Allen et al (1990a) Immunol. Ser. 49:1.
Allen et al (1990b) Marrow Biology and Stem Cells. In Colony Stimulating Factors: Molecular and Cellular Biology, edited by T.M. Dexter, J.M. Garland and N.G. Testa: New York: Marcel Decker, 1990b. pp. 1-38.
Anklesaria et al (1989) Blood. 74:1144.
Anklesaria et al (1987) Proc. Natl. Acad. Sci. USA. 84:7681.
Bennett et al (1991) Journal of Cell Science. 99:131.
Bentley (1982) Br J Haematol. 50:1.
Castro-Malaspina et al (1980) Blood. 56:289.
Castro-Malaspina et al. (1981) Blood. 57:781.
Dexter et al. (1977) J Cell Physiol. 91:335.
Dexter et al Kroc Foundation Series vol. 18; Alan R. Liss, Inc., New York; p. 57-96. 1984.
Fong et al (1997) BioTechniques. 23:1029.
Friedenstein (1976) International Review of Cytology. 47:327.
Friedenstein et al (1970) Cell Tissue Kinetics. 3:393.
Friedenstein et al. (1992) Bone and Mineral. 18:199.
Friedenstein (1980) “Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo.” Immunology of Bone Marrow Transplantation; Ed: S. Thienfelder; Springer-Verlag Berlin; p. 19-29, 1980.
Gronthos et al. (1994) Blood. 84:4164.
Gronthos and Simmons (1995) Blood. 85:929.
Huang and Terstappen (1992) Nature. 360:745.
Keating et al. (1982) Nature. 298: 280.
Kim et al. (1994) Science, 266:2011.
Knopse et al. (1966) Blood. 28:398.
Knopse et al. (1972) Blood. 39:331.
Lichtman (1981) Experimental Hematology. 9:391.
Long (1992) Exp Hematol. 20:288.
MacManus and Weiss (1984) Blood. 64:1036.
McIntyre and Bjornson (1986) Exp Hematol. 14:833.
Miltenyi et al. (1990) Cytometry. 11:231.
Owen (1985) Bone and Mineral Research. 3:1.
Owen and Friedenstein (1988) CIBA Foundation symposium. 136:42.
Perkins and Fleischman (1990) Blood. 75:620.
Piersma et al. (1983) Br. J. Haematol. 54:285.
Rothstein et al. (1985) Blood. 65:744.
Simmons and Gronthos. (1991) International Journal of Cell Cloning. 9:408 [abstract].
Simmons et al.(1994) Advances in Bone Marrow Purging and Processing: Fourth International Symposium. Progress in Clinical Biological Research. 389:271.
Simmons et al. (1987) Nature 328:429.
Simmons and Torok-Storb (1991a) Blood. 78:55.
Simmons and Torok-Storb (1991b) Blood. 78:2848.
Tavassoli and Friedenstein (1983) Ann J Hematol. 15:195.
Tavassoli and Crosby (1968) Science. 161:54.
Testa et al. (1988) Long-term Bone Marrow Damage after Cytotoxic Treatment:Stem Cells and Microenvironment in Hematopoiesis: Long-term Effects of Chemotherapy and Radiation (Hematology/vol. 8), eds. Testa, N.G., Gale, R.P., Marcel Dekker, Inc. New York and Basel, 1988, pp. 75-92.
Van Vlasselaer et al (1994) Blood. 84:753.
Waller et al. (1995) Blood. 85:2422.
Weiss (1976) Anatomical Record. 186:161.
Clarke, Emer, “Mesenchymal Cells” www.stemcell.com (mini-review).
Hellstrom et al. (1999) Development 126, 2047.
Zoltowska, et al. (2001) Arch Immunol Ther Exp (Warsz) 49:59-61.
Doherty, M.J. et al. (1998) “Vascular Pericytes Express Osteogenic Potential In Vitro and In Vitro”J. Bone and Mineral Research13, pp. 828-838.
Gronthos, S. et al. (2002) “Stem Cell Properties of Human Dental Pulp Stem Cells”J. Dent. Res. 81(8), pp. 531-535.
Jones, E.A. et al. (2002) “Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells”Arthritis&Rheumatism46(12), pp. 3349-3360.
Shi, S. et al. (2001) “Comparison of Human Dental Pulp and Bone Marrow Stromal Stem Cells by cDNA Microarray Analysis”Bone29(6), pp. 532-539.
Axelrad et al. New Technologies for the Enhancement of Skeletal Repair, Injury, Int. J. Care Injured (2007) 38S1:S49-S62.
Bruder et al., Mesenchymal Stem Cells in Bone Development, Bone Repair, and Skeletal Regeneration Therapy, J. Cell Biochem; (1994) 56:283-294.
Dennis et al., Osteogenesis in Marrow-Derived Mesenchymal Cell Porous Ceramic Composites Transplanted Subcutaneously: Effect of Fibronectin and Laminin on Cell Retention and Rate of Osteogenic Expression, Cell Transplant (1992) 1:23-32, Abstract.
Gronthos et al. Journal of Hematotherapy, 1996. 5, 15-23.
Shi S et al: “Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.” Journal of Bone and Mineral Research, vol. 17, No. Suppl 1, Sep. 2002, p. S446, XP009083412 & Twenty-Fourth Annual meeting of the American Society for Bone and Mineral Research; San Antonio, Texas, USA; Sep. 20-24, 2002.
Gronthos S et al: “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.” Proceedings of the National Academy of Sciences of USA, National Academy of Science, Washington, DC, US, vol. 97, No. 25, Dec. 5, 2000, pp. 13625-13630.
Shi S et al: “Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.” Journal of Bone and Mineral Research, New York, NY, US, vol. 18, No. 4, Apr. 2003, p. 696-704.
Tse H F et al: “Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.” Lancet The, Lancet Limited, London, GB, vol. 361, No. 9351, Jan. 4, 2003, pp. 47-49.
Zvaifler, et al., (2000) “Mesenchymal precursor cells in the blood of normal individuals,” Arthritis Research and Therapy, 2: 477-488.
Ji, et al., (2004) “Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury,” Stem Cells, 22: 415-427.
Sordi, et al., (2005) “Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to
Gronthos Stan
Simmons Paul
Zannettino Andrew
Angioblast Systems, Incorporated
Belyavskyi Michail A
Cooper & Duncan LLP
White John P.
LandOfFree
Mesenchymal precursor cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mesenchymal precursor cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mesenchymal precursor cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2788131